-+ 0.00%
-+ 0.00%
-+ 0.00%

STRUCTURE THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL STUDY OF ORAL SMALL MOLECULE AMYLIN RECEPTOR AGONIST ACCG-2671 FOR THE TREATMENT OF OBESITY

Reuters·12/17/2025 13:30:01

Please log in to view news